DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "General Anaesthesia Drugs Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025" report to their offering.
This industry offers a 10-year forecast of the global general anaesthesia drugs market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 3.8% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the general anaesthesia drugs market over the forecast period.
Increasing incidences of cardiovascular and chronic diseases, coupled with rising demand for surgical procedures is predicted to increase usages of general anaesthesia drugs worldwide. This is expected to bolster growth of the general anaesthesia drugs market over the next five to six years. Increasing demand for inhalation general anaesthesia drugs, for maintaining the sedative stage during surgical procedures, especially among the children and elderly population is expected to drive growth of general anaesthesia drugs market during the forecast period.
Companies are focused on populations driving the market such as: Asia Pacific and MEA, where incidences of cardiovascular and chronic disease are increasing, this is expected to further increase the demand of general anaesthesia drugs during surgical procedures.
Key Segments Covered:
- Product Type
Key Topics Covered:
1. Assumptions & Acronyms Used
2. Research Methodology
3. Executive Summary
4. Global General Anaesthesia Drugs Market
5. Global General Anaesthesia Drugs Market Overview
6. Global General Anaesthesia Drugs Market Outlook, By Product
7. Global General Anaesthesia Drugs Market Outlook, By Region
8. Global General Anaesthesia Drugs Market, By Region
9. Competitive Landscape
- Baxter International Inc.
- AbbVie Inc.
- B. Braun Melsungen AG s
- Fresenius SE & Co. KGaA
For more information visit http://www.researchandmarkets.com/research/mgnrcr/general